Robert A. Fletcher

3.0k total citations · 2 hit papers
82 papers, 2.0k citations indexed

About

Robert A. Fletcher is a scholar working on Computational Mechanics, Atmospheric Science and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Robert A. Fletcher has authored 82 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Computational Mechanics, 14 papers in Atmospheric Science and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Robert A. Fletcher's work include Diabetes Treatment and Management (14 papers), Atmospheric chemistry and aerosols (11 papers) and Particle Dynamics in Fluid Flows (9 papers). Robert A. Fletcher is often cited by papers focused on Diabetes Treatment and Management (14 papers), Atmospheric chemistry and aerosols (11 papers) and Particle Dynamics in Fluid Flows (9 papers). Robert A. Fletcher collaborates with scholars based in United States, Australia and United Kingdom. Robert A. Fletcher's co-authors include Richard A. Dobbins, Huan‐Cheng Chang, Wenyun Lu, Bruce A. Benner, G. Pilcher, Greg Gillen, George W. Mulholland, Maria Zambon, Daniel H. Goldhill and William Barclay and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Environmental Science & Technology.

In The Last Decade

Robert A. Fletcher

75 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria

2023 132 citations Brendon L. Neuen, Hiddo J.L. Heerspink et al. Circulation profile →
Cardiovascular, Kidney, and Safety Outcomes With GLP-1 Receptor Agonists Alone and in Combination With SGLT2 Inhibitors in Type 2 Diabetes: A Systematic Review and Meta-Analysis

2024 43 citations Brendon L. Neuen, Robert A. Fletcher et al. Circulation profile →

Peers

Countries citing papers authored by Robert A. Fletcher

Since Specialization

Citations

This map shows the geographic impact of Robert A. Fletcher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Fletcher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Fletcher more than expected).

Fields of papers citing papers by Robert A. Fletcher

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert A. Fletcher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Fletcher. The network helps show where Robert A. Fletcher may publish in the future.

Co-authorship network of co-authors of Robert A. Fletcher

This figure shows the co-authorship network connecting the top 25 collaborators of Robert A. Fletcher. A scholar is included among the top collaborators of Robert A. Fletcher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert A. Fletcher. Robert A. Fletcher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Canagliflozin Reduces Oral Loop Diuretic Intensification in Patients with Type 2 Diabetes: A Participant-Level Pooled Analysis of the CANVAS and CREDENCE Trials 2025 ·European Journal of Heart Failure ·Safia Chatur, Muthiah Vaduganathan, Robert A. Fletcher, Vlado Perkovic, Hiddo J.L. Heerspink, Clare Arnott, Carol A. Pollock, Kenneth W. Mahaffey, Bruce Neal, Meg Jardine, Scott D. Solomon, Brendon L. Neuen	1
2	Predicting cardiovascular events from routine mammograms using machine learning 2025 ·Heart ·Jennifer Barraclough, Ziba Gandomkar, Robert A. Fletcher, Sebastiano Barbieri, (unknown), Anthony Rodgers, Kirsty Douglas, Katrina Poppe, Mark Woodward, (unknown), Bruce Neal, Louisa Jorm, Patrick Brennan, Clare Arnott	1
3	The potential for reducing greenhouse gas emissions through disease prevention: a secondary analysis of data from the CREDENCE trial 2024 ·The Lancet Planetary Health ·(unknown), Robert A. Fletcher, Bruce Neal, Megumi Oshima, Fiona Adshead, Keith M. Moore, Forbes McGain, Scott McAlister, Katherine A. Barraclough, John Knight, Brendon L. Neuen, Clare Arnott	5
4	Machine learning for prediction of chronic kidney disease progression: Validation of the Klinrisk model in the CANVAS Program and CREDENCE trial 2024 ·Diabetes Obesity and Metabolism ·Navdeep Tangri, Thomas W. Ferguson, (unknown), Silvia J. Leon, Clare Arnott, Kenneth W. Mahaffey, Sradha Kotwal, Hiddo J.L. Heerspink, Vlado Perkovic, Robert A. Fletcher, Brendon L. Neuen	12
5	The Effect of Weight Loss Through Lifestyle Interventions in Patients With Heart Failure With Preserved Ejection Fraction—A Systematic Review and Meta-Analysis of Randomised Controlled Trials 2024 ·Heart Lung and Circulation ·Vivian Y. Lee, (unknown), (unknown), Jennifer Barraclough, Arianne Sweeting, Jie Yu, Robert A. Fletcher, Clare Arnott	10
6	Effect of SGLT2 Inhibitors on Discontinuation of Renin–angiotensin System Blockade: A Joint Analysis of the CREDENCE and DAPA-CKD Trials 2023 ·Journal of the American Society of Nephrology ·Robert A. Fletcher, Niels Jongs, Glenn M. Chertow, John J.V. McMurray, Clare Arnott, Meg Jardine, Kenneth W. Mahaffey, Vlado Perkovic, Patrick Rockenschaub, Peter Rossing, Ricardo Correa‐Rotter, Robert D. Toto, Muthiah Vaduganathan, David C. Wheeler, Hiddo J.L. Heerspink, Brendon L. Neuen	14
7	Kidney protection with canagliflozin: A combined analysis of the randomized CANVAS program and CREDENCE trials 2023 ·Diabetes Obesity and Metabolism ·Vikas S. Sridhar, Brendon L. Neuen, Robert A. Fletcher, April Slee, (unknown), (unknown), Clare Arnott, David Z.I. Cherney, Vlado Perkovic, David C. Wheeler, Adeera Levin	5
8	Estimated Lifetime Cardiovascular, Kidney, and Mortality Benefits of Combination Treatment With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Nonsteroidal MRA Compared With Conventional Care in Patients With Type 2 Diabetes and Albuminuria breakdown → 2023 ·Circulation ·Brendon L. Neuen, Hiddo J.L. Heerspink, Priya Vart, Brian Claggett, Robert A. Fletcher, Clare Arnott, (unknown), Michael O. Falster, Sallie‐Anne Pearson, Kenneth W. Mahaffey, Bruce Neal, Rajiv Agarwal, George L. Bakris, Vlado Perkovic, Scott D. Solomon, Muthiah Vaduganathan	132
9	Canagliflozin, Blood Pressure Variability, and Risk of Cardiovascular, Kidney, and Mortality Outcomes: Pooled Individual Participant Data From the CANVAS and CREDENCE Trials 2023 ·Journal of the American Heart Association ·Robert A. Fletcher, Clare Arnott, Patrick Rockenschaub, Aletta E. Schutte, Lewis Carpenter, Muthiah Vaduganathan, Rajiv Agarwal, George L. Bakris, Tara I. Chang, Hiddo J.L. Heerspink, Meg Jardine, Kenneth W. Mahaffey, Bruce Neal, Carol A. Pollock, Min Jun, Anthony Rodgers, Vlado Perkovic, Brendon L. Neuen	4
10	The effects of canagliflozin in type 2 diabetes in subgroups defined by population‐specific body mass index: Insights from the CANVAS Program and CREDENCE trial 2023 ·Diabetes Obesity and Metabolism ·Jie Yu, Arianne Sweeting, (unknown), (unknown), Vivian Y. Lee, Robert A. Fletcher, Vlado Perkovic, Qiang Li, Brendon L. Neuen, Otávio Berwanger, Hiddo J.L. Heerspink, Dick de Zeeuw, Clare Arnott	5
11	Effects of newer kidney protective agents on kidney endpoints provide implications for future clinical trials 2023 ·Kidney International ·Hiddo J.L. Heerspink, Niels Jongs, Brendon L. Neuen, Patrick Schloemer, Muthiah Vaduganathan, Lesley A. Inker, Robert A. Fletcher, David C. Wheeler, George L. Bakris, Tom Greene, Glenn M. Chertow, Vlado Perkovic	8
12	Certification of New Standard Reference Material 2806b Medium Test Dust in Hydraulic Oil 2016 ·Journal of Research of the National Institute of Standards and Technology ·Robert A. Fletcher, Nicholas W. M. Ritchie, David S. Bright, James J. Filliben, (unknown)	3
13	Optimized thermal desorption for improved sensitivity in trace explosives detection by ion mobility spectrometry 2012 ·The Analyst ·(unknown), (unknown), Matthew E. Staymates, Robert A. Fletcher, Greg Gillen	97
14	Production and characterization of polymer microspheres containing trace explosives using precision particle fabrication technology 2009 ·Journal of Microencapsulation ·Matthew E. Staymates, Robert A. Fletcher, Jessica L. Staymates, Greg Gillen, Cory Berkland	10
15	Inkjet Metrology and Standards for Ion Mobility Spectrometry 2007 ·International Journal for Ion Mobility Spectrometry ·R. Michael Verkouteren, (unknown), (unknown), Robert A. Fletcher, (unknown), (unknown), John G. Gillen	4
16	NIST Program to Support Testing and Evaluation of Trace Explosive Detection \| NIST 2007 ·Journal of Testing and Evaluation ·R. Michael Verkouteren, John G. Gillen, Jennifer R. Verkouteren, Robert A. Fletcher, (unknown), (unknown)	1
17	Existence of Young Soot in the Exhaust of Inverse Diffusion Flames. \| NIST 2002 ·Proceedings of the Combustion Institute ·Linda Gail Blevins, Robert A. Fletcher, Bruce A. Benner, Eric B. Steel, George W. Mulholland	1
18	Mass Spectrometry of Particles Formed in a Deuterated Ethene (C2D4) Diffusion Flame \| NIST 1998 ·Analytical Chemistry ·Robert A. Fletcher, Richard A. Dobbins, H. C. Chang	1
19	Microchemical and Molecular Dating \| NIST 1989 ·Radiocarbon ·Lloyd A. Currie, Thomas W. Stafford, (unknown), George A. Klouda, Stephen A. Wise, Robert A. Fletcher, D. J. Donahue, A. J. T. Jull, T W Linick	1
20	Microchemical and molecular dating. 1989 ·Radiocarbon ·Lloyd A. Currie, Thomas W. Stafford, (unknown), George A. Klouda, Stephen A. Wise, Robert A. Fletcher, Douglas J. Donahue, A. J. T. Jull, T W Linick	23

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact